TMA Precision Health and Dante Genomics partner to help children with rare diseases through clinical whole genome sequencing solutions
NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced its partnership with TMA Precision Health, a company on a mission to improve the lives of rare disease patients everywhere, offering clinical whole genome sequencing to rare disease patients as the first step in diagnosing and treating disease with more personalized medicine.
“The simple act of providing a whole genome sequence is likely the single most important piece of healthcare for a patient with a rare disease, and no child or family should have to needlessly suffer because they can’t afford it,” said Joshua Resnikoff, CEO and Cofounder of TMA Precision Health. “Our mission is to bring this service to those that need it most. We are thrilled to partner with Dante Genomics to bring the highest quality genomic sequencing and interpretation services to our patients around the globe.”
Dante Genomics will provide 30X whole genome sequencing, clinical interpretation and personalized genomic reports to TMA’s patient network of more than 3.5 million people living with rare diseases for the purposes of diagnosis.
“There are so many people, especially children, suffering from undiagnosed rare diseases around the world, and it is this unmet need that we are working to serve every day,” said Andrea Riposati, CEO and co-founder of Dante Genomics. “We must work to end any diagnostic odyssey for these patients and reduce the time to diagnosis from years to days. Children with a rare disease, in any country, deserve the best clinical care, and TMA Precision Health is at the frontier to bring genomic driven care to the countries with the highest unmet need.”
Dante Genomics will utilize the genomic data related to this partnership to advance internal research related to novel target identification and drug development with the ultimate goal to go beyond diagnosis to treatment of rare disease.
TMA will incorporate the data from this partnership to continue growing the largest rare disease database in the world, with a focus on developing precision medicine solutions for rare patients everywhere.
About TMA Precision Health
TMA Precision Health is on a mission to provide personalized care and health equity for rare disease patients around the world. Our unique access to more than 3.5 million rare disease patients powers our ability to build on-demand comprehensive datasets of paired de-identified medical records and whole genomic sequencing and identify rare patients for clinical trials, giving our pharma partners a competitive edge when researching new insights and developing new treatments for this area of critically unmet need. For more information, please visit tmaprecisionhealth.com and follow us on LinkedIn.
About Dante Genomics
Dante Genomics is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The Company uses its platform to deliver better patient outcomes from diagnostics to therapeutics with assets including one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Automox Expands Functionality and Reach with Remote Control and New Global Partnership4.10.2022 15:00:00 CEST | Press release
Product and distribution momentum set to fuel international growth Boulder, Colo, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Automox®, the cloud-native IT operations provider, today announced general availability of its remote control feature, offering global IT teams advanced troubleshooting capabilities from a single cloud-native console. Remote control is a powerful tool for IT teams everywhere. IT administrators often face a mountain of device-related issues daily, ranging from email account errors, password resets, and devices that won’t update, to processes that drain device resources. Without the ability to perform an in-depth investigation directly on the device, providing a fix generally requires significant time from IT teams and multiple tools. With remote control, IT admins can gain immediate access to end-user devices to troubleshoot issues directly. The functionality was developed in-house by Automox’s product team to help IT teams quickly address a wide array of common endpoint i
Huhtamaki launches innovative, recyclable ice cream packaging solution in the US, made with 95% renewable biobased material4.10.2022 15:00:00 CEST | Press release
HUHTAMÄKI OYJ PRESS RELEASE 04.10.2022 AT 16.00 EEST Huhtamaki launchesinnovative, recyclableice cream packaging solution in the US, made with 95% renewable biobased material Paper-based technology allows packaging to enter the North American paper recycling system easily.ConnectedPackaging QR code provides consumers with more information on sustainability. Huhtamaki, a key global provider of sustainable packaging solutions, today launches ICON® packaging, a breakthrough paper technology, initially for use for ice cream containers and lids, which enables recycling in communities with paper product recycling programs across the United States. This is a significant breakthrough in delivering a sustainable solution for consumers which combines Huhtamaki’s proprietary water-based barrier coating with SFI-certified paperboard and results in the entire package being made with 95% renewable biobased material. This enables the ice cream containers and lids to be recycled along with other paper
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland4.10.2022 13:00:00 CEST | Press release
Tilray’s Medical Cannabis Product Now Available and Reimbursed Under Ireland’s Medical Cannabis Access Program LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that it has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP). Tilray’s approved product has also recently received reimbursement approval, which gives patients cost reimbursement and ensures more eligible patients can access quality medical cannabis under Ireland’s MCAP. Denise Faltischek, Tilray Brands’ Chief Strategy Officer and Head of International Business, said, “We are extremely proud to relaunch in Ireland with an expanded footprint. The MCAP reimbursement approval is a tremendous step in providi
Moore Nanotechnology Systems Opens Global Training and Process Development Center in Charlotte, North Carolina4.10.2022 13:00:00 CEST | Press release
SWANZEY, N.H., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Moore Nanotechnology Systems (“Nanotech”), a leading global supplier of ultra-precision machining systems, announces the grand opening of their Global Training and Process Development Center in Charlotte, North Carolina. Mark Boomgarden, President and CEO of Nanotech shared, “Nanotech is very excited to announce the grand opening of our Global Training and Process Development Center in Charlotte, North Carolina. Although the initial focus of this facility is to provide customer-specific training and industry-leading process development, it also provides Nanotech incremental production capacity to meet the demands of a rapidly growing market.” Nanotech purchased and recently completed the upfit of a 50,000 ft2 building located in the Northpark Corporate Park - Charlotte, NC. Nanotech’s core technology and employee base is in Swanzey, New Hampshire, and this foundation is fundamental to the products and services in which they provide. But
FRO - Changes to the Board composition4.10.2022 08:06:57 CEST | Press release
Frontline Ltd. (“Frontline” or “the Company”) announces the appointment of Mr. Marios Demetriades as a Director of the Company. Marios Demetriades is an experienced Financial Services professional with significant experience as a Non-Executive Director in various listed and private companies in the Banking, Infrastructure and Shipping industries. He previously served as the Minister of Transport, Communications and Works for the Republic of Cyprus from 2014 to 2018 and held various positions in the Accounting, Investment and Banking sectors. He is a qualified Chartered Accountant and Chartered Financial Analyst holder and a member of the CFA Institute, the Institute of Chartered Accountants in England and Wales and the Institute of Certified Public Accountants of Cyprus (ICPAC). Mr. Demetriades is a Cypriot citizen and resides in Cyprus. October 4, 2022 The Board of Directors Frontline Ltd. Hamilton, Bermuda Questions should be directed to: Lars H. Barstad, Chief Executive Officer, Fro